Preventive Care
Conference Coverage
Greater fracture risk reduction seen with denosumab vs. zoledronic acid in postmenopausal women
The analysis took extra pains to remove bias through data that might be linked to potential confounders but could not reasonably be attributed to...
Conference Coverage
New RSV vaccine will cut hospitalizations, study shows
With widespread use of the vaccine, annual hospitalizations resulting from infant RSV would fall by 51%, emergency department encounters would...
News
CPAP adherence curbs severe cardiovascular disease outcomes
Meta-analysis supports the need for better strategies to improve CPAP adherence in high-risk populations.
Commentary
Multivitamins and dementia: Untangling the COSMOS study web
When you get a positive result in your research, it’s always exciting. But when a slew of studies that came before you are negative, you aren’t...
News
Vegetarian diets tied to lower risk for some GI cancers
“The results of this systematic review indicate that adherence to vegetarian diets can reduce the risk of gastrointestinal cancers, compared with...
News
Endoscopic monitoring may not be needed for nonerosive GERD
Patients with confirmed nonerosive GERD are not at greater risk for esophageal cancer but those with erosive disease had more than double the...
News
Are vitamin D levels key to canagliflozin’s fracture risk?
“Something as simple as OTC vitamin D might protect against bone fractures caused by chronic multiyear treatment with a drug.”
Conference Coverage
New risk factors for cardiovascular disease in women emerging
Gender equity in care for cardiovascular disease will be achieved only when risk factors are evaluated from a gender-dependent perspective and...
News
Fish oil labels make health claims, despite lack of data
“What was surprising, though, was just how broad the types of claims being made were – from heart and brain health to joint health, eye health,...
News
Is this the best screening test for prostate cancer?
Researchers from the United Kingdom found that half of men with apparently “safe” PSA levels had clinically significant prostate cancers when...